Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Stem cell transplantation.

Steven Fruchtman¹

¹Mount Sinai School of Medicine, One East 100th Street, New York, NY 10029, USA.

The Mount Sinai Journal of Medicine, New York

|May 24, 2003

Summary

Bone marrow transplants using stem cells from matched donors have transformed fatal hematological disorders into treatable conditions. This progress necessitates ethical discussions for patients and donors involved in these life-saving procedures.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The Incidence and Health Care Resource Burden of the Myelodysplastic Syndromes in Patients in Whom First-Line Hypomethylating Agents Fail.

The oncologist·2017

Same author

Treatment of polycythemia vera with imatinib mesylate.

Leukemia research·2011

Same author

Jumping translocations of the long arms of chromosome 1 in myeloid malignancies is associated with a high risk of transformation to acute myeloid leukaemia.

British journal of haematology·2010

Same author

Transcriptional profiling of polycythemia vera identifies gene expression patterns both dependent and independent from the action of JAK2V617F.

Clinical cancer research : an official journal of the American Association for Cancer Research·2010

Same author

New approaches to the treatment of thrombocytosis.

Clinical advances in hematology & oncology : H&O·2005

Same author

Allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning in intermediate- or high-risk patients with myelofibrosis with myeloid metaplasia.

Blood·2005

Area of Science:

Hematology
Immunology
Medical Ethics

Background:

Historically, bone marrow disorders like leukemia and aplastic anemia were fatal.
Advances in stem cell transplantation have improved outcomes for these conditions.
Transplantation now utilizes sibling, unrelated, or cord blood stem cells.

Purpose of the Study:

To review the evolution of bone marrow stem cell transplantation.
To highlight the expanded donor pool beyond siblings.
To underscore the ethical considerations arising from these advancements.

Main Methods:

Review of historical and recent scientific literature on bone marrow transplantation.
Analysis of the progression in donor selection criteria.
Identification of emerging ethical concerns in stem cell donation.

Main Results:

Hematopoietic stem cell transplantation has significantly improved survival rates for previously fatal bone marrow diseases.
The sources for hematopoietic stem cells have diversified to include unrelated donors and cord blood.
The expansion of donor options introduces complex ethical issues.

Conclusions:

Bone marrow transplantation represents a major therapeutic advance in hematology.
Ethical discussions are crucial for patients, donors, and healthcare professionals.
Informed consent and ethical guidelines are paramount for current and future transplantation practices.

Related Experiment Videos